Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.1K Sell
19,450
-360
-2% -$1.13K 0.01% 409
2026
Q1
$57.8K Buy
19,810
+4,443
+29% +$12.7K 0.01% 404
2025
Q4
$38K Sell
15,367
-623
-4% -$1.48K ﹤0.01% 452
2025
Q3
$35.7K Sell
15,990
-3,805
-19% -$8.71K ﹤0.01% 462
2025
Q2
$47.7K Sell
19,795
-31
-0.2% -$75 0.01% 426
2025
Q1
$46.2K Sell
19,826
-1,408
-7% -$2.82K 0.01% 418
2024
Q4
$39.3K Buy
21,234
+1,184
+6% +$2.62K 0.01% 390
2024
Q3
$48.9K Buy
20,050
+8,403
+72% +$18.8K 0.01% 360
2024
Q2
$23.9K Sell
11,647
-11,642
-50% -$26.5K ﹤0.01% 416
2024
Q1
$57.8K Buy
23,289
+944
+4% +$2.46K 0.01% 355
2023
Q4
$62.6K Sell
22,345
-25
-0.1% -$68 0.01% 332
2023
Q3
$57.7K Sell
22,370
-786
-3% -$2.27K 0.01% 341
2023
Q2
$73.6K Buy
23,156
+142
+0.6% +$418 0.01% 320
2023
Q1
$64.9K Buy
23,014
+949
+4% +$2.48K 0.01% 343
2022
Q4
$60K Buy
+22,065
New +$64.3K 0.01% 350

Other funds holding ABEV

Grove Bank & Trust's ABEV Position: Q2 2026 in Review

Grove Bank & Trust reduced its Ambev (ABEV) stake by 1.8% in Q2 2026, selling an estimated $1.13K and leaving 19,450 shares worth $61.1K. The position accounts for 0.01% of the portfolio, ranked #409.

Grove Bank & Trust first reported a position in ABEV in Q4 2022 and has held it in 15 quarters since. The position peaked at $73.6K in Q2 2023. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Grove Bank & Trust held 19,450 shares of Ambev worth $61.1K as of Q2 2026.
  • Grove Bank & Trust sold 360 Ambev shares in Q2 2026, an estimated $1.13K.
  • Ambev made up 0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #409 holding.
  • Grove Bank & Trust first reported a position in Ambev in Q4 2022 and has held it in 15 quarters since.
  • Grove Bank & Trust's Ambev position peaked at $73.6K in Q2 2023.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.